96 related articles for article (PubMed ID: 1548878)
1. The effect of elevated levels of thromboxane on host response to tumor.
Waymack JP; Fernandes G; Venkatraman J; Flescher E; Yurt RW; Guzman RF; Mason AD; Pruitt BA
J Surg Oncol; 1992 Jan; 49(1):3-9. PubMed ID: 1548878
[TBL] [Abstract][Full Text] [Related]
2. Effect of prostaglandin E in multiple experimental models. VIII. Effect on host response to metastatic tumor.
Waymack JP; Flescher E; Venkatraman J; Fernandes G; Guzman RF; Yurt RW; Mason AD; Pruitt BA
J Surg Oncol; 1991 Dec; 48(4):239-45. PubMed ID: 1745048
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of renal vasoconstriction with thromboxane mimetic: engagement of tubuloglomerular feedback.
Welch WJ; Wilcox CS; Folger WH
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():693-6. PubMed ID: 1825399
[TBL] [Abstract][Full Text] [Related]
4. Roles of thromboxanes in gastrointestinal physiopathology.
Bennett TA
Int J Tissue React; 1983; 5(3):237-9. PubMed ID: 6686219
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of thromboxane B2 accumulation and metabolism in perfused guinea-pig lung.
Hoult JR; Robinson C
Br J Pharmacol; 1983 Jan; 78(1):85-8. PubMed ID: 6824820
[TBL] [Abstract][Full Text] [Related]
6. Effects of thromboxane A2 on lymphocyte proliferation.
Ceuppens JL; Vertessen S; Deckmyn H; Vermylen J
Cell Immunol; 1985 Feb; 90(2):458-63. PubMed ID: 3155656
[TBL] [Abstract][Full Text] [Related]
7. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
8. Bay U 3405 inhibits cerebral vasospasm induced by authentic thromboxane A2.
Braun M; Schrör K
Stroke; 1990 Dec; 21(12 Suppl):IV152-4. PubMed ID: 2260141
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-beta bioactivity in mesangial cells.
Studer RK; Negrete H; Craven PA; DeRubertis FR
Kidney Int; 1995 Aug; 48(2):422-30. PubMed ID: 7564109
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
Harris RH; Nichols R; Schmeling JW; Ramwell PW
Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
[No Abstract] [Full Text] [Related]
11. The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT and 5-CT in the human isolated umbilical artery.
Templeton AG; McGrath JC; Whittle MJ
Br J Pharmacol; 1991 May; 103(1):1079-84. PubMed ID: 1878747
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2 analogue (U-46619) stimulates vascular PGI2 synthesis.
Jeremy JY; Mikhailidis DP; Dandona P
Eur J Pharmacol; 1985 Jan; 107(2):259-62. PubMed ID: 3884343
[TBL] [Abstract][Full Text] [Related]
13. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
Quilley J; McGiff JC; Nasjletti A
Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of antagonism of thromboxane receptors in vascular smooth muscle.
Yanagisawa A; Smith JA; Brezinski ME; Lefer AM
Eur J Pharmacol; 1987 Jan; 133(1):89-96. PubMed ID: 3030773
[TBL] [Abstract][Full Text] [Related]
15. Characterization of thromboxane and prostacyclin effects on pulmonary vascular resistance.
Barnard JW; Ward RA; Adkins WK; Taylor AE
J Appl Physiol (1985); 1992 May; 72(5):1845-53. PubMed ID: 1534797
[TBL] [Abstract][Full Text] [Related]
16. Diabetes alters the reactivity of myocardium to a thromboxane analogue.
Canga L; Gorelik G; Sterin-Borda L
Can J Physiol Pharmacol; 1987 Apr; 65(4):499-503. PubMed ID: 2886201
[TBL] [Abstract][Full Text] [Related]
17. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J
Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
[No Abstract] [Full Text] [Related]
18. Modulation of thromboxane receptor activation in rat glomerular mesangial cells.
Spurney RF; Middleton JP; Raymond JR; Coffman TM
Am J Physiol; 1994 Sep; 267(3 Pt 2):F467-78. PubMed ID: 8092261
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
Br J Pharmacol; 1981 Jul; 73(3):773-8. PubMed ID: 7248665
[TBL] [Abstract][Full Text] [Related]
20. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
Patscheke H; Stegmeier K
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
